Zenlabs Ethica
31.70
+1.13(+3.70%)
Market Cap₹19.90 Cr
PE Ratio74.55
Company Performance:
1D+3.70%
1M-0.94%
6M+1.41%
1Y-22.83%
5Y+36.93%
View Company Insightsright
Latest news about Zenlabs Ethica
Zenlabs Ethica Reports Strong Q1 FY2026 Results with 21.9% Revenue Growth Aug 09, 2025
Zenlabs Ethica Limited reported impressive Q1 FY2026 results. Revenue increased by 21.9% to ₹957.50 crore. EBITDA grew by 29.4% to ₹212.98 crore, with margin expanding to 22.2%. Profit After Tax surged by 50.9% to ₹131.90 crore. The company launched three new products, filed two ANDAs with USFDA, received approval for one generic product, and commenced production at a new facility. Zenlabs maintains a strong financial position with net cash of ₹205.98 crore.
Zenlabs Ethica Reports Q1 Profit Dip, Adopts New Insider Trading Policies Aug 08, 2025